Search Results:
Records found: 10
| Case No. |
Title |
Date |
Author(s) |
| BME11 |
Lessons from Pharmaceutical Product Litigation: Merck and the Vioxx Withdrawal, Cona & McDarby vs. Merck |
2010 |
Margaret L. Eaton
|
| BME6 |
Developing and Marketing a Blockbuster Drug: Lessons from Eli Lilly's Experience with Prozac |
2006 |
Margaret L. Eaton; Mark Xu
|
| BME4 |
Genzyme and the Research Ethics Questions Associated with its NeuroCell-PD Trials |
2005 |
Margaret L. Eaton; Tara Thiagarajan; Mark Hong
|
| BME3 |
Myriad and OncorMed and the Marketing of the First Genetic Tests for Breast Cancer Susceptibility |
2005 |
Margaret L. Eaton; Rebecca Farkas; Daniel Greenwald
|
| BME1 |
VaxGen, Inc., Fighting the AIDS Epidemic |
2005 |
Margaret L. Eaton; Jennifer Wilds; Betty Pang
|
| BME2 |
Zeneca�s Direct-to-Consumer Advertising of Nolvadex |
2005 |
Margaret L. Eaton; Jason Ehrlich; Naveen Chopra
|
| BME8 |
Adiana, Inc., and the Development of a Female Sterilization Device |
2004 |
Margaret L. Eaton; Anjali Reddi; Aradhana Sarin
|
| BME10 |
Geron Corporation and the Role of Ethics Advice |
2004 |
Margaret L. Eaton; Clare Risa Ozawa; Gerald M. Farquharson
|
| BME9 |
Merck's US. Managed Distribution Program For The HIV Drug Crixivan |
2004 |
Margaret L. Eaton; Madhuri Mani Roy; Marko Curavic
|
| BME7 |
Novartis - UC Berkeley Research Collaboration |
2004 |
Margaret L. Eaton
|
|
|
Start new search
|
|
